Association Between US Drug Price and Measures of Efficacy for Oncology Drugs Approved by the US Food and Drug Administration From 2015 to 2020

This cross-sectional study estimates all US Food and Drug Administration anticancer approvals in recent years and evaluates if an association exists between their cost and efficacy.

Detalles Bibliográficos
Autores principales: Miljković, Miloš D., Tuia, Jordan E., Olivier, Timothée, Haslam, Alyson, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9623474/
https://www.ncbi.nlm.nih.gov/pubmed/36315136
http://dx.doi.org/10.1001/jamainternmed.2022.4924
Descripción
Sumario:This cross-sectional study estimates all US Food and Drug Administration anticancer approvals in recent years and evaluates if an association exists between their cost and efficacy.

Ejemplares similares